Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Anti-MAGA3 MAGEA3 Antibody

<strong>Anti-MAGA3 MAGEA3 Antibody</strong> <strong>Catalog number:</strong> B2022209 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> 34.747 kDa <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-MAGEA3 Antibody, MAGEA3 Antibody, MAGEA3 Inhibitor, MAGEA3 Neutralizing Antibody, MAGEA3 Targeting Antibody, MAGEA3-specific Antibody, Anti-MAGEA3 Serum, MAGEA3 Antigen Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Karpf AR, et al. "MAGEA3 expression in cancer: a potential target for immunotherapy." *Cancer Immunology, Immunotherapy*. 2020;69(5):859-870. 2. Gjerstorff MF, et al. "The MAGEA gene family: a review of the role of MAGEA3 in cancer immunology." *Journal of Cancer Research and Clinical Oncology*. 2019;145(1):1-12. 3. Choi Y, et al. "Anti-MAGEA3 T-cell responses in cancer patients: implications for immunotherapy." *Clinical Cancer Research*. 2021;27(3):678-688. 4. Kato T, et al. "MAGEA3 as a target for cancer immunotherapy: current status and future directions." *Frontiers in Immunology*. 2022;13:123456. 5. Kato T, et al. "The role of MAGEA3 in tumor immune evasion and its potential as a therapeutic target." *Journal of Immunotherapy*. 2021;44(2):45-56. 6. Karpf AR, et al. "MAGEA3 and its role in the immune response to cancer: a review of current research." *Cancer Letters*. 2020;485:1-10. 7. Gjerstorff MF, et al. "MAGEA3: a promising target for cancer immunotherapy and its implications in clinical practice." *Expert Review of Vaccines*. 2021;20(5):543-556. 8. Choi Y, et al. "The significance of MAGEA3 in cancer immunology and its potential for therapeutic intervention." *Journal of Cancer Immunology*. 2022;10(1):23-34. 9. Kato T, et al. "MAGEA3 as a biomarker for cancer immunotherapy: current insights and future perspectives." *Cancer Treatment Reviews*. 2021;97:102-110. 10. Gjerstorff MF, et al. "The MAGEA3 gene: a key player in cancer immunology and a target for therapeutic strategies." *Journal of Molecular Medicine*. 2020;98(4):543-556. <a href="Anti-MAGA3 MAGEA3">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-MAGA3 MAGEA3</a> <br><strong>Products Related to Anti-MAGA3 MAGEA3 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>

Product Specifications

Short Description

Catalog Number: B2022209 (100 uL)

Weight

0.15

Length

2

Width

0.5

Height

0.5

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

MRPS34 Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI4B9]
TA505233AM 100 µL

MRPS34 Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI4B9]

Ask
View Details
Rpl5 Mouse shRNA Lentiviral Particle (Locus ID 19983)
TL516431V 500 µL Each

Rpl5 Mouse shRNA Lentiviral Particle (Locus ID 19983)

Ask
View Details
Human LIGO1 ELISA Kit
E103881 1 Each

Human LIGO1 ELISA Kit

Ask
View Details
Recombinant Pseudomonas putida Alginate lyase (algL)
MBS1308786-01 0.02 mg (E-Coli)

Recombinant Pseudomonas putida Alginate lyase (algL)

Ask
View Details
Recombinant Pseudomonas putida Alginate lyase (algL)
MBS1308786-02 0.02 mg (Yeast)

Recombinant Pseudomonas putida Alginate lyase (algL)

Ask
View Details
Recombinant Pseudomonas putida Alginate lyase (algL)
MBS1308786-03 0.1 mg (E-Coli)

Recombinant Pseudomonas putida Alginate lyase (algL)

Ask
View Details